Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-10-16

Clinical Trial Update: Mefloquine Bioequivalence Among 3 Commercially Available Tablets.

View source ↗

Summary

This completed study evaluated the bioequivalence of three commercially available mefloquine tablet formulations for malaria prevention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lariam (mefloquine hydrochloride)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Malaria | Status: COMPLETED